OpenFilings

EyePoint Pharmaceuticals, Inc.

Form10-K

Report Period2021-12-31

Date Filed2022-03-14

Time Filed19:44:45

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K
EX-10.19
EX-10.28
EX-10.45
EX-10.46
EX-21.1
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
Filing on SEC Edgar